Results 21 to 30 of about 554 (132)

Hemodynamics of Transcatheter Tricuspid Valve Replacement With Lux-Valve

Frontiers in Cardiovascular Medicine, 2022
ObjectiveTranscatheter tricuspid valve intervention (TTVI) has emerged as an alternative treatment option for high-risk and inoperable patients with symptomatic tricuspid regurgitation (TR).
Fanglin Lu, Bailing Li
exaly   +3 more sources

Burden of Heart Failure in Patients With Tricuspid Regurgitation and Effect of Transcatheter Repair on Different Subdimensions of Quality of Life

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Right‐sided heart failure (HF) due to severe tricuspid regurgitation (TR) is associated with reduced quality of life (QoL). Here, we analyzed the impact of TR on specific QoL dimensions and the effect of transcatheter tricuspid valve ...
Thomas J. Stocker, Saskia Sommer, David J. Cohen, John A. Spertus, Lukas Stolz, Philipp M. Doldi, Ludwig T. Weckbach, Michael Nabauer, Steffen Massberg, Jörg Hausleiter   +9 more
doaj   +2 more sources

Exploration of Anesthetic Strategies for Transcatheter Tricuspid Valve Intervention [PDF]

Reviews in Cardiovascular Medicine
Tricuspid regurgitation (TR) is a critical factor in the progression of right heart failure. Although conventional open surgery remains the definitive treatment, the application of this technique is significantly limited in older and high-risk patients ...
Shuantong Lin, Yulong Guan
doaj   +2 more sources

Comparative efficacy and safety of transcatheter edge-to-edge repair versus tricuspid valve replacement versus optimal medical therapy in moderate-to-severe tricuspid regurgitation: a network meta-analysis of randomized controlled trials [PDF]

Journal of Cardiothoracic Surgery
Background Severe tricuspid regurgitation (TR) is associated with substantial morbidity and increased mortality. Transcatheter edge-to-edge repair (TEER) and transcatheter tricuspid valve replacement (TTVR) have emerged as less-invasive options for ...
Ihsan Noushad Karuppan Veettil, Anuhya Jamandlamudi, Nebeela Abdul Khader, Tea Shehu, Doris Lacej, Shivangi Jha, Obawole Mayowa, Joshua Zumba, Temirlan Ismailov, Zhanel Almaganbetova, Bertha Gabriela, Lina Hajjar, Sifat Ullah Safi, Muneeb Khawar   +13 more
doaj   +2 more sources

Simplified Outcome Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention by Survival Tree-Based Modelling [PDF]

JACC: Advances
Background: Patients with severe tricuspid regurgitation (TR) typically present with heterogeneity in the extent of cardiac dysfunction and extra-cardiac comorbidities, which play a decisive role for survival after transcatheter tricuspid valve ...
Vera Fortmeier, MD, Mark Lachmann, MD, Lukas Stolz, MD, Jennifer von Stein, MD, Karl-Philipp Rommel, MD, Mohammad Kassar, MD, Muhammed Gerçek, MD, Anne R. Schöber, MD, Thomas J. Stocker, MD, Hazem Omran, MD, Michelle Fett, Jule Tervooren, Maria I. Körber, MD, Amelie Hesse, Gerhard Harmsen, PhD, Kai Peter Friedrichs, MD, Shinsuke Yuasa, MD, PhD, Tanja K. Rudolph, MD, Michael Joner, MD, Roman Pfister, MD, Stephan Baldus, MD, Karl-Ludwig Laugwitz, MD, Stephan Windecker, MD, Fabien Praz, MD, Philipp Lurz, MD, Jörg Hausleiter, MD, Volker Rudolph, MD   +26 more
doaj   +3 more sources

Clinical and Echocardiographic Outcomes of Transcatheter Tricuspid Valve Interventions: A Systematic Review and Meta-Analysis

Frontiers in Cardiovascular Medicine, 2022
BackgroundMedically managed tricuspid regurgitation (TR) has detrimental outcomes. Transcatheter tricuspid valve interventions (TTVIs) represent an alternative to surgery in high-risk patients; however, only early experiences exist.AimThe aim of this ...
Patrizio Lancellotti, Federica Ilardi, Philipp Lurz   +2 more
exaly   +3 more sources

Time to Assess More Than Prognosis: Advancements and Challenges in Transcatheter Tricuspid Valve Interventions

Frontiers in Cardiovascular Medicine
We provide an overview about the current landscape of transcatheter tricuspid valve interventions (TTVI) and summarize recent findings from trials including TRILUMINATE, TRILUMINATE Pivotal, bRIGHT, TRICLASP, TRISCEND, TRISCEND II, TRICUS, and Cardioband
Volker Rudolph, Tanja K Rudolph, Kai P Friedrichs   +2 more
exaly   +3 more sources

Management of Tricuspid Valve Regurgitation Consensus Recommendations [PDF]

Heart Views
Tricuspid regurgitation (TR) is a prevalent condition historically associated with high mortality and underrecognition. While medical therapy remains common, standalone surgical interventions involve significant perioperative risks.
Sondos Samargandy, Bander Alshuhri, Burkhard Mackensen, Fawaz Almutairi, Gilbert H. L. Tang, Lamia Alshengheti, Mohammad Alreshidan, Mohammed Al-Hijji, Zakariya Albinmousa   +8 more
doaj   +2 more sources

Transcatheter repair of a quadricuspid tricuspid valve with severe regurgitation: a case report [PDF]

Journal of Cardiothoracic Surgery
Background Moderate-to-severe tricuspid regurgitation (TR) represents the most prevalent right heart disorder. If left untreated, it may progress to heart failure and elevate mortality risk.
Jingyuan Huo, Qiyao Yu, Kaishuai Wu, Chen Wang, Haoyang Li, Zhen Wang, Weidong Li, Hongfei Xu   +7 more
doaj   +2 more sources

Transcatheter Intervention Is Associated With Visceral Decongestion in Patients With Severe Tricuspid Regurgitation. [PDF]

Clin Cardiol
Patients with severe symptomatic tricuspid regurgitation were assigned to transcatheter tricuspid valve intervention. Most patients showed discontinuous renal vein blood flow (arrows, Grade IV°) prior to TTVI (baseline). At follow‐up after 1 to 3 months, patients showed continuous renal vein blood flow profile (arrows, Grade I°) representing a marked ...
Putz FJ, Spahn J, Kranert PC, Grewe F, Haus M, Wester M, Bienert V, Trum M, Schach C, Luchner A, Birner C, Unsöld B, Banas MC, Banas B, Maier LS, Debl K, Paulus M, Meindl C.   +17 more
europepmc   +2 more sources